Celexor Bio
celexorbio.com
Actively hiring
As featured in
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials
Overview
At Celexor Bio, we aim to solve the challenges of severe autoimmune disorders by starting at the source – stopping the inflammatory cascade and modifying the course of disease.
News
Aditum Bio forms Celexor Bio, focused on cell depletion of pathologic cells in autoimmune and inflammatory disorders
Aditum Bio forms Celexor Bio, focused on cell depletion of pathologic cells in autoimmune and inflammatory disorders
Read more
Report
Report
New Celexor Bio to focus on cell depletion of pathologic cells in autoimmune and inflammatory disorders
Inmagene Biopharmaceuticals Technology (Shanghai) Co. Ltd. and biotech investment firm Aditum Bio Management Company LLC have announced the formation of Celexor Bio, a new biotech company focused on cell depletion of pathologic cells in autoimmune and inf
Read more
Report
Aditum Bio Announces Formation of Celexor Bio, Focused on Cell Depletion of Pathologic Cells in Autoimmune and Inflammatory Disorders
/PRNewswire/ -- Aditum Bio, the biotech investment firm cofounded in 2019 by former Novartis CEO Joe Jimenez and former President of the Novartis Institutes...
Read more
Report
Inmagene announces formation of Celexor Bio based on its anti-ILT7 mAb with enhanced pDC depletion function
/PRNewswire/ -- Inmagene Biopharmaceuticals (Inmagene), a clinical-stage biotech company developing innovative and differentiated therapies for immunological...
Read more
Report
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1